Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

被引:1331
作者
Feng, Rui-Mei [1 ]
Zong, Yi-Nan [1 ]
Cao, Su-Mei [1 ]
Xu, Rui-Hua [2 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Canc Prevent,Res Ctr,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
关键词
GLOBCAN; 2018; Cancer pattern; China; USA; UK; Carcinogenic risk factor; Tobacco smoking; Chronic infection; Westernized lifestyles; Cancer control strategies; UNITED-STATES; SMOKING; DEATHS;
D O I
10.1186/s40880-019-0368-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is the leading cause of death in China and depicting the cancer pattern of China would provide basic knowhows on how to tackle it more effectively. In this study we have reviewed several reports of cancer burden, including the Global cancer statistics 2018 and Cancer statistics in China, 2015, along with the GLOBCAN 2018 online database, to investigate the differences of cancer patterns between China, the United States (USA) and the United Kingdom (UK). An estimated 4.3 million new cancer cases and 2.9 million new cancer deaths occurred in China in 2018. Compared to the USA and UK, China has lower cancer incidence but a 30% and 40% higher cancer mortality than the UK and USA, among which 36.4% of the cancer-related deaths were from the digestive tract cancers (stomach, liver, and esophagus cancer) and have relatively poorer prognoses. In comparison, the digestive cancer deaths only took up <= 5% of the total cancer deaths in either USA or UK. Other reasons for the higher mortality in China may be the low rate of early-stage cancers at diagnosis and non-uniformed clinical cancer treatment strategies performed by different regions. China is undergoing the cancer transition stage where the cancer spectrum is changing from developing country to developed country, with a rapidly increase cancer burden of colorectal, prostate, female breast cancers in addition to a high occurrence of infection-related and digestive cancers. The incidence of westernized lifestyle-related cancers in China (i.e. colorectal cancer, prostate, bladder cancer) has risen but the incidence of the digestive cancers has decreased from 2000 to 2011. An estimated 40% of the risk factors can be attributed to environmental and lifestyle factors either in China or other developed countries. Tobacco smoking is the single most important carcinogenic risk factor in China, contributing to similar to 24.5% of cancers in males. Chronic infection is another important preventable cancer contributor which is responsible for similar to 17% of cancers. Comprehensive prevention and control strategies in China should include effective tobacco-control policy, recommendations for healthier lifestyles, along with enlarging the coverage of effective screening, educating, and vaccination programs to better sensitize greater awareness control to the general public.
引用
收藏
页数:12
相关论文
共 19 条
[1]  
[Anonymous], TOB SURV REP AD CHIN
[2]  
[Anonymous], BR J CANC
[3]  
[Anonymous], GLOB CANC OBS CANC T
[4]  
[Anonymous], IARC CANCERBASE
[5]   Status of implementation and organization of cancer screening in The European Union Member StatesSummary results from the second European screening report [J].
Basu, Partha ;
Ponti, Antonio ;
Anttila, Ahti ;
Ronco, Guglielmo ;
Senore, Carlo ;
Vale, Diama Bhadra ;
Segnan, Nereo ;
Tomatis, Mariano ;
Soerjomataram, Isabelle ;
Zakelj, Maja Primic ;
Dillner, Joakim ;
Elfstrom, Klara Miriam ;
Lonnberg, Stefan ;
Sankaranarayanan, Rengaswamy .
INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (01) :44-56
[6]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[7]   Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study [J].
de Sanjose, Silvia ;
Quint, Wim G. V. ;
Alemany, Laia ;
Geraets, Daan T. ;
Ellen Klaustermeier, Jo ;
Lloveras, Belen ;
Tous, Sara ;
Felix, Ana ;
Eduardo Bravo, Luis ;
Shin, Hai-Rim ;
Vallejos, Carlos S. ;
Alonso de Ruiz, Patricia ;
Lima, Marcus Aurelho ;
Guimera, Nuria ;
Clavero, Omar ;
Alejo, Maria ;
Llombart-Bosch, Antonio ;
Cheng-Yang, Chou ;
Alejandro Tatti, Silvio ;
Kasamatsu, Elena ;
Iljazovic, Ermina ;
Odida, Michael ;
Prado, Rodrigo ;
Seoud, Muhieddine ;
Grce, Magdalena ;
Usubutun, Alp ;
Jain, Asha ;
Hernandez Suarez, Gustavo Adolfo ;
Estuardo Lombardi, Luis ;
Banjo, Aekunbiola ;
Menendez, Clara ;
Javier Domingo, Efren ;
Velasco, Julio ;
Nessa, Ashrafun ;
Chichareon, Saibua C. Bunnag ;
Qiao, You Lin ;
Lerma, Enrique ;
Garland, Suzanne M. ;
Sasagawa, Toshiyuki ;
Ferrera, Annabelle ;
Hammouda, Doudja ;
Mariani, Luciano ;
Pelayo, Adela ;
Steiner, Ivo ;
Oliva, Esther ;
Meijer, Chris J. L. M. ;
Al-Jassar, Waleed Fahad ;
Cruz, Eugenia ;
Wright, Thomas C. ;
Puras, Ana .
LANCET ONCOLOGY, 2010, 11 (11) :1048-1056
[8]   Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind [J].
Espina, Carolina ;
Soerjomataram, Isabelle ;
Forman, David ;
Martin-Moreno, Jose M. .
JOURNAL OF CANCER POLICY, 2018, 18 :40-51
[9]   Present status of human papillomavirus vaccine development and implementation [J].
Herrero, Rolando ;
Gonzalez, Paula ;
Markowitz, Lauri E. .
LANCET ONCOLOGY, 2015, 16 (05) :E206-E216
[10]   Screening for breast cancer in England: a review [J].
Hogben, Rosalyn Katy F. .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2008, 20 (06) :545-549